BDNF and depressive symptom measurement: The current psychobiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) treatment for eight weeks significantly improved depression-like behavior by upregulating BDNF levels in patients with depression compared to the placebo group [174].